LIFE Annual SG&A
$12.98 M
-$1.00 M-7.17%
31 December 2023
Summary:
As of January 27, 2025, LIFE annual selling, general & administrative expenses is $12.98 million, with the most recent change of -$1.00 million (-7.17%) on December 31, 2023. During the last 3 years, it has risen by +$3.90 million (+43.02%).LIFE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE Quarterly SG&A
$3.51 M
+$303.00 K+9.46%
31 March 2024
Summary:
As of January 27, 2025, LIFE quarterly selling, general & administrative expenses is $3.51 million, with the most recent change of +$303.00 thousand (+9.46%) on March 31, 2024. Over the past year, it has increased by +$99.00 thousand (+2.90%).LIFE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE TTM SG&A
-$1.85 B
-$53.93 M-3.01%
31 March 2024
Summary:
As of January 27, 2025, LIFE TTM selling, general & administrative expenses is -$1.85 billion, with the most recent change of -$53.93 million (-3.01%) on March 31, 2024. Over the past year, it has dropped by -$1.86 billion (-13378.13%).LIFE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.2% | +2.9% | -10000.0% |
3 y3 years | +43.0% | +1.7% | -10000.0% |
5 y5 years | +4.4% | +38.5% | -10000.0% |
LIFE Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -24.0% | -40.5% | <-9999.0% |
ATyr Pharma Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2024 | - | $3.51 M(+9.5%) | $13.08 M(+0.8%) |
Dec 2023 | $12.98 M(-7.2%) | $3.20 M(+21.0%) | $12.98 M(-1.7%) |
Sept 2023 | - | $2.65 M(-28.8%) | $13.20 M(-6.9%) |
June 2023 | - | $3.72 M(+9.1%) | $14.18 M(+1.9%) |
Mar 2023 | - | $3.41 M(-0.5%) | $13.91 M(-0.5%) |
Dec 2022 | $13.98 M(+30.1%) | $3.43 M(-5.5%) | $13.98 M(+5.6%) |
Sept 2022 | - | $3.63 M(+5.1%) | $13.24 M(+8.5%) |
June 2022 | - | $3.45 M(-0.9%) | $12.21 M(+5.7%) |
Mar 2022 | - | $3.48 M(+29.7%) | $11.55 M(+7.4%) |
Dec 2021 | $10.75 M(+18.5%) | $2.69 M(+3.7%) | $10.75 M(+3.8%) |
Sept 2021 | - | $2.59 M(-7.2%) | $10.36 M(+5.6%) |
June 2021 | - | $2.79 M(+3.9%) | $9.81 M(+7.0%) |
Mar 2021 | - | $2.69 M(+17.0%) | $9.17 M(+1.1%) |
Dec 2020 | $9.07 M(-3.0%) | $2.29 M(+12.3%) | $9.07 M(-2.4%) |
Sept 2020 | - | $2.04 M(-4.8%) | $9.30 M(+1.8%) |
June 2020 | - | $2.15 M(-17.1%) | $9.13 M(-2.9%) |
Mar 2020 | - | $2.59 M(+2.9%) | $9.41 M(+0.6%) |
Dec 2019 | $9.35 M(-24.8%) | $2.52 M(+33.6%) | $9.35 M(+1.1%) |
Sept 2019 | - | $1.88 M(-22.2%) | $9.25 M(-6.0%) |
June 2019 | - | $2.42 M(-4.4%) | $9.84 M(-9.7%) |
Mar 2019 | - | $2.53 M(+4.9%) | $10.90 M(-12.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | $12.44 M(-27.2%) | $2.41 M(-2.5%) | $12.44 M(-21.8%) |
Sept 2018 | - | $2.48 M(-28.8%) | $15.91 M(-7.1%) |
June 2018 | - | $3.48 M(-14.6%) | $17.13 M(-0.1%) |
Mar 2018 | - | $4.07 M(-30.9%) | $17.14 M(+0.4%) |
Dec 2017 | $17.08 M(+13.1%) | $5.89 M(+59.4%) | $17.08 M(+17.2%) |
Sept 2017 | - | $3.69 M(+5.9%) | $14.57 M(+1.6%) |
June 2017 | - | $3.49 M(-13.0%) | $14.35 M(-4.3%) |
Mar 2017 | - | $4.01 M(+18.4%) | $14.99 M(-0.7%) |
Dec 2016 | $15.09 M(+15.1%) | $3.38 M(-2.5%) | $15.09 M(-2.8%) |
Sept 2016 | - | $3.47 M(-15.9%) | $15.52 M(-0.7%) |
June 2016 | - | $4.13 M(+0.3%) | $15.63 M(+4.9%) |
Mar 2016 | - | $4.12 M(+7.9%) | $14.90 M(+13.6%) |
Dec 2015 | $13.11 M(+93.5%) | $3.81 M(+6.7%) | $13.11 M(+19.3%) |
Sept 2015 | - | $3.57 M(+5.2%) | $10.99 M(+19.0%) |
June 2015 | - | $3.40 M(+45.8%) | $9.23 M(+22.1%) |
Mar 2015 | - | $2.33 M(+37.9%) | $7.56 M(+11.6%) |
Dec 2014 | $6.78 M(+18.7%) | $1.69 M(-7.2%) | $6.78 M(+33.2%) |
Sept 2014 | - | $1.82 M(+5.6%) | $5.09 M(+55.7%) |
June 2014 | - | $1.73 M(+11.9%) | $3.27 M(+111.9%) |
Mar 2014 | - | $1.54 M | $1.54 M |
Dec 2013 | $5.71 M | - | - |
FAQ
- What is aTyr Pharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for aTyr Pharma?
- What is aTyr Pharma annual SG&A year-on-year change?
- What is aTyr Pharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for aTyr Pharma?
- What is aTyr Pharma quarterly SG&A year-on-year change?
- What is aTyr Pharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for aTyr Pharma?
- What is aTyr Pharma TTM SG&A year-on-year change?
What is aTyr Pharma annual selling, general & administrative expenses?
The current annual SG&A of LIFE is $12.98 M
What is the all time high annual SG&A for aTyr Pharma?
aTyr Pharma all-time high annual selling, general & administrative expenses is $17.08 M
What is aTyr Pharma annual SG&A year-on-year change?
Over the past year, LIFE annual selling, general & administrative expenses has changed by -$1.00 M (-7.17%)
What is aTyr Pharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of LIFE is $3.51 M
What is the all time high quarterly SG&A for aTyr Pharma?
aTyr Pharma all-time high quarterly selling, general & administrative expenses is $5.89 M
What is aTyr Pharma quarterly SG&A year-on-year change?
Over the past year, LIFE quarterly selling, general & administrative expenses has changed by +$99.00 K (+2.90%)
What is aTyr Pharma TTM selling, general & administrative expenses?
The current TTM SG&A of LIFE is -$1.85 B
What is the all time high TTM SG&A for aTyr Pharma?
aTyr Pharma all-time high TTM selling, general & administrative expenses is $17.14 M
What is aTyr Pharma TTM SG&A year-on-year change?
Over the past year, LIFE TTM selling, general & administrative expenses has changed by -$1.86 B (-13378.13%)